These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 2891701

  • 1. Aspartate transcarbamylase from Leishmania donovani. A discrete, nonregulatory enzyme as a potential chemotherapeutic site.
    Mukherjee T, Ray M, Bhaduri A.
    J Biol Chem; 1988 Jan 15; 263(2):708-13. PubMed ID: 2891701
    [Abstract] [Full Text] [Related]

  • 2. Overproduction of the first three enzymes of pyrimidine nucleotide biosynthesis in Drosophila cells resistant to N-phosphonacetyl-L-aspartate.
    Laval M, Azou Y, Giorgi D, Rosset R.
    Exp Cell Res; 1986 Apr 15; 163(2):381-95. PubMed ID: 2869965
    [Abstract] [Full Text] [Related]

  • 3. N-(Phosphonacetyl)-L-aspartate inhibition of the enzyme complex of pyrimidine biosynthesis.
    Moore EC.
    Biochem Pharmacol; 1982 Oct 15; 31(20):3313-6. PubMed ID: 7150357
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Kinetic parameters of aspartate transcarbamylase in human normal and tumoral cell lines.
    Baillon J, Guichard M, Malaise EP, Hervé G.
    Cancer Res; 1983 May 15; 43(5):2277-82. PubMed ID: 6831451
    [Abstract] [Full Text] [Related]

  • 9. The overall synthesis of L-5,6-dihydroorotate by multienzymatic protein pyr1-3 from hamster cells. Kinetic studies, substrate channeling, and the effects of inhibitors.
    Christopherson RI, Jones ME.
    J Biol Chem; 1980 Dec 10; 255(23):11381-95. PubMed ID: 6108323
    [Abstract] [Full Text] [Related]

  • 10. Aspartate carbamoyltransferase activity, drug concentrations, and pyrimidine nucleotides in tissue from patients treated with N-(phosphonacetyl)-L-aspartate.
    Moore EC, Friedman J, Valdivieso M, Plunkett W, Marti JR, Russ J, Loo TL.
    Biochem Pharmacol; 1982 Oct 15; 31(20):3317-21. PubMed ID: 7150358
    [Abstract] [Full Text] [Related]

  • 11. Peripheral leukocytes as indicators of the enzymatic effects of N-(phosphonacetyl)-L-aspartic acid (PALA) on human L-aspartate transcarbamoylase (ATCase) activity.
    Kensler TW, Erlichman C, Jayaram HN, Tyagi AK, Ardalan B, Cooney DA.
    Cancer Treat Rep; 1980 Oct 15; 64(8-9):967-73. PubMed ID: 7448831
    [Abstract] [Full Text] [Related]

  • 12. Effects of acivicin and PALA, singly and in combination, on de novo pyrimidine biosynthesis.
    Kensler TW, Jayaram HN, Cooney DA.
    Adv Enzyme Regul; 1982 Oct 15; 20():57-73. PubMed ID: 7113804
    [Abstract] [Full Text] [Related]

  • 13. Overexpression of the 18 kDa and 22/24 kDa FGF-2 isoforms results in differential drug resistance and amplification potential.
    Dini G, Funghini S, Witort E, Magnelli L, Fanti E, Rifkin DB, Del Rosso M.
    J Cell Physiol; 2002 Oct 15; 193(1):64-72. PubMed ID: 12209881
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Mechanism of resistance of variants of the Lewis lung carcinoma to N-(phosphonacetyl)-L-aspartic acid.
    Kensler TW, Mutter G, Hankerson JG, Reck LJ, Harley C, Han N, Ardalan B, Cysyk RL, Johnson RK, Jayaram HN, Cooney DA.
    Cancer Res; 1981 Mar 15; 41(3):894-904. PubMed ID: 7459875
    [Abstract] [Full Text] [Related]

  • 19. Binding of radiolabeled N-(phosphonacetyl)-L-aspartate to aspartate transcarbamylase from Ehrlich ascites tumor cells.
    White JC, Hines LH.
    Biochem Pharmacol; 1984 Nov 15; 33(22):3645-8. PubMed ID: 6508821
    [Abstract] [Full Text] [Related]

  • 20. The effects of pH and inhibitors upon the catalytic activity of the dihydroorotase of multienzymatic protein pyr1-3 from mouse Ehrlich ascites carcinoma.
    Christopherson RI, Jones ME.
    J Biol Chem; 1980 Apr 25; 255(8):3358-70. PubMed ID: 6102565
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.